PhArmacoVIgilance Africa (PAVIA) is a consortium that has recently been funded by the European Developing countries Clinical Trials Partnership (EDCTP). The PAVIA project aims to strengthen pharmacovigilance (PV) in four African countries: Ethiopia, Nigeria, Swaziland, and Tanzania. To achieve this aim, collaborative support will be harnessed across several institutions in Europe and Africa.

Find a visual presentation of PAVIA in this presentation:  Generic project presentation PAVIA (179 downloads)

In each of the participating countries, a uniquely designed active triangle will lead the project. This triangle will consist of an intense collaboration of; i) National Medicine Regulatory Authority (including the national pharmacovigilance unit), ii) National Public Health Programme introducing a new product, and; iii) local Medical Research Institutes (MRI).

PAVIA will have its initial activities premised on the introduction of new drugs and treatment regimens for multidrug-resistant tuberculosis (MDR-TB) by the National Tuberculosis Programs (NTPs). PAVIA’s focus will include strengthening the processes of routine adverse event reporting in accordance with country policies that already exist (or which will be put in place or strengthened during the course of the PAVIA project). In addition, expert guidance will be provided on causality assessment, signal detection and training at the national and lower levels to support the linkage process between disease control programmes (notably the NTPs) and the National Regulatory Authorities/Pharmacovigilance Agencies.

PAVIA organogram

At the end of the project, PAVIA will deliver a blueprint for strengthening pharmacovigilance that can serve other Sub-Sahara African countries.

PAVIA will work closely with its sister project PROFORMA that is also funded through EDCTP.


The PAVIA project team uses ORCID, a non-profit organization that connects researchers with their work, contributions, and affiliations. It contributes to the standardization of research information and enables authors to be more clearly attributed to their work.



The PAVIA Coordination Office encourages its members to open an ORCID account and include their ORCID identifier on their webpage, when they submit publications, apply for grants, and in any research workflow to ensure their profile and work is identified and connected. Currently, more than 30 PAVIA members have registered to ORCID.